Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Aspire Biopharma(ASBP) the Revenue is 63.1 K (--%);the EBIT is -2.449 M (-206.1%);the EPS is -1.22 (+97.46%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.00B206.14%
----
----
EPS
-1.221997.46%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf